Please use this identifier to cite or link to this item:
|Title:||A CD8+ T cell transcription signature predicts prognosis in autoimmune disease||Authors:||McKinney, E.F.
|Issue Date:||May-2010||Citation:||McKinney, E.F., Lyons, P.A., Carr, E.J., Hollis, J.L., Jayne, D.R.W., Willcocks, L.C., Koukoulaki, M., Brazma, A., Jovanovic, V., Kemeny, D.M., Pollard, A.J., MacAry, P.A., Chaudhry, A.N., Smith, K.G.C. (2010-05). A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nature Medicine 16 (5) : 586-591. ScholarBank@NUS Repository. https://doi.org/10.1038/nm.2130||Abstract:||Autoimmune diseases are common and debilitating, but their severe manifestations could be reduced if biomarkers were available to allow individual tailoring of potentially toxic immunosuppressive therapy. Gene expression-based biomarkers facilitating such tailoring of chemotherapy in cancer, but not autoimmunity, have been identified and translated into clinical practice. We show that transcriptional profiling of purified CD8+ T cells, which avoids the confounding influences of unseparated cells, identifies two distinct subject subgroups predicting long-term prognosis in two autoimmune diseases, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a chronic, severe disease characterized by inflammation of medium-sized and small blood vessels, and systemic lupus erythematosus (SLE), characterized by autoantibodies, immune complex deposition and diverse clinical manifestations ranging from glomerulonephritis to neurological dysfunction. We show that the subset of genes defining the poor prognostic group is enriched for genes involved in the interleukin-7 receptor (IL-7R) pathway and T cell receptor (TCR) signaling and those expressed by memory T cells. Furthermore, the poor prognostic group is associated with an expanded CD8+ T cell memory population. These subgroups, which are also found in the normal population and can be identified by measuring expression of only three genes, raise the prospect of individualized therapy and suggest new potential therapeutic targets in autoimmunity.||Source Title:||Nature Medicine||URI:||http://scholarbank.nus.edu.sg/handle/10635/107634||ISSN:||10788956||DOI:||10.1038/nm.2130|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.